Key result
Homograft aortic valve replacement, pioneered in 1962, revolutionized cardiac valve surgery by eliminating the need for postoperative anticoagulation and reducing thromboembolic complications.
This editorial honors the pioneers of homograft aortic valve replacement, a revolutionary procedure that eliminated the need for postoperative anticoagulation.
First, I would like to seize this great opportunity to honor 2 pioneer surgeons and teachers: Mr. Donald Ross in London and Sir Brian Barratt-Boyes in Auckland, New Zealand, for their achievements and contributions in homograft valve surgery. In June and July 1962, they independently pioneered the first successful replacement of a diseased aortic valve with a homograft aortic valve1,2 following experimental work by Duran and Gunning in Oxford. The procedure was revolutionary in the history of cardiac valve surgery in the last millennium because postoperative anticoagulation was not needed and there were no inherent thromboembolic complications, thus giving patients a better quality of life. I invite cardiac surgeons across the globe to join me in congratulating them on their achievements.
No takes yet. Share an insight, caveat, or question.
A. C. Yankah (2002) conducted an editorial in Diseased aortic valve. Homograft aortic valve replacement was evaluated. Homograft aortic valve replacement, pioneered in 1962, revolutionized cardiac valve surgery by eliminating the need for postoperative anticoagulation and reducing thromboembolic complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: